Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai

International Journal for Vitamin and Nutrition Research

Volumn 76, Issue 3, 2006, Pages 125-131

  Chanchay, Siriporn ^a   Tungtrongchitr, Rungsunn ^a   Harnroongroj, Talabporn ^a   Phonrat, Benjaluck ^a   Rungseesakorn, Orapin ^b   Paksanont, Suporn ^a   Pooudong, Somchai ^a   Saowakontha, Sastri ^b   Varongchayakul, Chusak ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b BURAPHA UNIVERSITY   (Thailand)

^c Bang Yai Hospital   (Thailand)

Author keywords

Diabetes; Insulin; Obese Thai; Resistin

Indexed keywords

GLUCOSE; INSULIN; RESISTIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; NUTRITIONAL STATUS; OBESITY; THAILAND; WAIST HIP RATIO;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; RADIOIMMUNOASSAY; RESISTIN; SKINFOLD THICKNESS; THAILAND; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 33750532094     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.76.3.125     Document Type: Article

References (23)

1. Jeffrey, S. F. (2001) The missing link with obesity? Nature 409, 292-293.
2. Steppan, C. M., Brown, E. J., Wright, C. M. et al. (2001) A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. 98, 502-506.
3. McTernan, C. L., McTernan, P. G., Harte, A. L., Levick, P. L., Barnett, A. H. and Kumar, S. (2002) Resistin, central obesity and type 2 diabetes. Lancet 359, 46-47.
4. McTernan, P. G., McTernan, C. L., Chetty, R. et al. (2002) Increased Resistin Gene and Protein Expression in Human Abdominal Adipose Tissue. J. Clin. Endocrinol. Metab. 87, 2407.
5. Yang, Y., Zhang, C., Tang, Z., Zhang, X. and Lu, Z. (2005) Experimental Studies on Capturing Human Leukocytes with Cell Immuno-Chip. Clin. Chem. 51, 910-911.
6. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
7. rd ed. W.B. Saunders, Philadelphia.
8. World Health Organization. (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organization Tech. Rep. Ser. 854, 1-452.
9. Degawa-Yamauchi, M., Bovenkerk, J. E., Juliar, B. E. et al. (1998) Serum Resistin (F1ZZ3) Protein Is Increased in Obese Humans. J. Clin. Endocrinol. Metab. 88(11), 5452-5455.
10. Azuma, K., Katsukawa, F., Oguchi, S. et al. (2003) Correlation between Serum Resistin Level and Adiposity in Obese Individuals. Obes. Res. 11, 997-1001.
11. Schaffler, A., Buchler, C., Muller-Ladner, U. et al. (2004) Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm. Metab. Res. 36, 702-707.
12. Volarova de Courten, B., Degawa-Yamauchi, M., Considine, R.V., and Antonio, P. (2004) Tataranni 1 High Serum Resistin Is Associated with an Increase in Adiposity but not a Worsening of Insulin Resistance in Pima Indians. Diabetes 53. 1279-1284.
13. Lee, J. H., Chan, J. L., Yiannakouris, N. et al. (2003) Circulating Resistin Levels are not Associated with Obesity or Insulin Resistance in Humans and are not Regulated by Fasting or Leptin Administration: Cross-Sectional and Interventional Studies in Normal, Insulin-Resistant, and Diabetic Subjects. J. Clin. Endocrinol. Metab. 88, 4848-4856.
14. Heilbronn, L. K., Rood, J., Janderova, L. et al. (2004) Relationship between Serum Resistin Concentrations and Insulin resistance in Non-Obese, Obese, and Obese Diabetic Subjects. J. Clin. Endocrinol. Metab. 89, 1844-1848.
15. Shetty, G. K., Economides, P. A., Horton, E. S., Mantzoros, C. S., and Veves, A. (2004) Circulating Adiponectin and Resistin Levels in Relation to Metabolic Factors, Inflammatory Markers, and Vascular Reactivity in Diabetic Patients and Subjects at Risk for Diabetes. Diabetes Care 27, 2450-2457.
16. Silha, J. V., Krsek, M., Skrha, J. V., Sucharda, P., Nyomba, B. L. G. and Murphy, L. J. (2003) Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. European Journal of Endocrinology 149, 331-335.
17. Youn, B. S., Yu, K. Y., Park, H. J. et al. (2004) Plasma Resistin Concentrations Measured by Enzyme-Linked Immunosorbent Assay Using a Newly Developed Monoclonal Antibody Are Elevated in Individuals with Type 2 Diabetes Mellitus. J. Clin. Endocrinol. Metab. 89, 150-156.
18. Pfützner, A., Pahler, S., Kunt, T. et al. (2004) Fasting Intact Proinsulin is a Highly Specific Predictor of Insulin Resistance in Type 2 Diabetes. Diabetes Care 27, 682-687.
19. Bonora, E., Targher, G., Alberiche, M. et al. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23, 57-63.
20. Wallace, T. M., Levy, J.C., and Matthews, D. R. (2004) Use and Abuse of HOMA Modeling. Diabetes Care 27, 1487-1495.
21. Haffner, S.M., Kennedy, E., Gonzalez, C., Stern, M. P. and Miettinen, H. (1996) A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care 19, 1138-1141.
22. Rajala, M. W., Obici, S., Scherer, Ph.E. and Rosseth, L. (2003) Adipose derived resistin and gut-derived resistin like molecule-β selectively impair insulin action on glucose protection. J. Clin. Invest. 111, 225-230.
23. Chen, C. C., Li, T. C., Li, C. I., Liu, C. S., Wang, H. J. and Lin, C. C. (2005) Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters. Metabolism 54, 471-475.